IRIS
CANTINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.191
AS - Asia 1.213
EU - Europa 988
SA - Sud America 215
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 2
Totale 5.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.110
SG - Singapore 449
CN - Cina 243
VN - Vietnam 222
IT - Italia 217
RU - Federazione Russa 182
BR - Brasile 164
HK - Hong Kong 126
DE - Germania 105
IE - Irlanda 92
SE - Svezia 83
GB - Regno Unito 67
FI - Finlandia 63
FR - Francia 62
CI - Costa d'Avorio 55
CA - Canada 40
IN - India 39
BD - Bangladesh 26
UA - Ucraina 26
MA - Marocco 21
PL - Polonia 19
JP - Giappone 18
AR - Argentina 16
MX - Messico 15
ZA - Sudafrica 13
BE - Belgio 12
CO - Colombia 12
IQ - Iraq 12
NL - Olanda 12
LT - Lituania 10
TR - Turchia 10
PH - Filippine 9
IL - Israele 8
PK - Pakistan 8
CZ - Repubblica Ceca 7
EC - Ecuador 7
UZ - Uzbekistan 7
EG - Egitto 6
ID - Indonesia 6
CR - Costa Rica 5
DK - Danimarca 5
ES - Italia 5
GT - Guatemala 5
HN - Honduras 5
KR - Corea 5
AT - Austria 4
RO - Romania 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
EU - Europa 3
NP - Nepal 3
PR - Porto Rico 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
DZ - Algeria 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
OM - Oman 2
PY - Paraguay 2
SC - Seychelles 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
LY - Libia 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
RS - Serbia 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 5.722
Salva come PNG Salva come JPEG
Città #
Ashburn 604
Singapore 324
Chandler 265
Des Moines 241
San Jose 186
Dallas 131
Hong Kong 123
New York 104
Fairfield 97
Dublin 86
Boardman 84
Council Bluffs 77
Munich 75
Beijing 65
Ho Chi Minh City 64
Los Angeles 59
Abidjan 55
Hanoi 53
Ann Arbor 51
Santa Clara 45
Seattle 45
Wilmington 45
Princeton 40
Woodbridge 39
Jacksonville 36
Houston 35
The Dalles 35
Turku 35
Cambridge 32
Lauterbourg 32
Lawrence 31
Turin 29
Buffalo 27
Helsinki 27
Chicago 26
Moscow 26
San Diego 26
San Mateo 25
Rome 22
Warsaw 19
London 18
Montreal 18
Da Nang 16
Pune 16
Washington 16
Atlanta 14
Phoenix 14
São Paulo 14
Ancona 13
Orem 13
Johannesburg 12
Tokyo 12
Boston 11
Brussels 11
Denver 11
Hefei 11
Milan 11
Haiphong 10
Salt Lake City 10
Baghdad 9
Poplar 9
Shanghai 8
Clovis 7
Rio de Janeiro 7
Tashkent 7
Urbisaglia 7
Vilnius 7
Amsterdam 6
Biên Hòa 6
Brooklyn 6
Columbus 6
Destin 6
Mexico City 6
Olomouc 6
Redmond 6
Shenzhen 6
Stockholm 6
Brasília 5
Chennai 5
Elk Grove Village 5
Falls Church 5
Manchester 5
Miano 5
Ninh Bình 5
Nuremberg 5
Porto Alegre 5
Tolentino 5
Wuhan 5
Zhengzhou 5
Arnold 4
Belo Horizonte 4
Bến Tre 4
Calgary 4
Can Tho 4
Charlotte 4
City of London 4
Fortaleza 4
Frankfurt am Main 4
Guangzhou 4
Guatemala City 4
Totale 3.897
Salva come PNG Salva come JPEG
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 263
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 214
Are liver nested stromal epithelial tumors always low aggressive? 211
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 207
Optimal management of resected gastric cancer 194
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 191
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 181
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 177
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 175
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 173
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 170
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 170
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 169
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 163
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study 153
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 151
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 149
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 142
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience 142
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy 139
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 139
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 135
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 135
Cancer patient perspective in the arena of COVID-19 pandemic 133
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study 131
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 129
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study 128
Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study 127
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 123
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study 120
Re: Comments on 'High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients' 115
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer 110
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 100
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 98
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy 98
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 94
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 93
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078] 91
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 84
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry 80
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumors 27
Totale 5.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022242 0 0 0 6 17 34 13 15 48 16 36 57
2022/2023853 53 88 39 67 42 284 0 43 139 8 71 19
2023/2024405 67 9 28 32 48 127 2 8 0 17 5 62
2024/2025921 148 75 38 18 39 51 74 38 156 41 116 127
2025/20262.490 202 135 135 268 363 193 414 228 203 200 78 71
2026/2027466 83 126 58 199 0 0 0 0 0 0 0 0
Totale 5.824